References
- Antipsychotic Medication Reference. (2012). Healthcare Quality Strategies, Inc. Antipsychotic Medication Reference. Retrieved from https://healthinsight.org/Internal/docs/nursing/antipsychotic_tool.pdf.
- Atypical Antipsychotic Drug Information. (2016). Center for Drug Evaluation and Research. Postmarket Drug Safety Information for Patients and Providers - Atypical Antipsychotic Drugs Information. Retrieved from https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm094303.htm
- CMS Announces National Partnership to Improve Dementia Care in Nursing Homes. (2012). CMS.gov. CMS Announces National Partnership to Improve Dementia Care in Nursing Homes. Retrieved from https://www.cms.gov/Newsroom/MediaReleaseDatabase/Press-Releases/2012-Press-Releases-Items/2012-05-30.html
- Data show National Partnership to Improve Dementia Care exceeds goals to reduce unnecessary antipsychotic medications in nursing homes. (2014). CMS.gov. Data show National Partnership to Improve Dementia Care exceeds goals to reduce unnecessary antipsychotic medications in nursing homes. Retrieved from https://www.cms.gov/newsroom/MediareleaseDatabase/Fact-sheets/2014-Fact-sheets-items/2014-09-19.html
- Dusetzina, S. B., Higashi, A. S., Dorsey, E. R., Conti, R., Huskamp, H. A., Zhu, S., … Alexander, G. C. (2012). Impact of FDA drug risk communications on health care utilization and health behaviors: A systematic review. Medical Care, 50(6), 466–478. doi:10.1097/MLR.0b013e318245a160
- Information for Healthcare Professionals: Conventional Antipyschotics. (2008). Center for Drug Evaluation and Research. Postmarket Drug Safety Information for Patients and Providers - Historical Information on Atypical Antipsychotic Drugs. Retrieved from http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm149296.htm
- Interim report on the CMS Nationial Partnership to Improve Dementia Care in Nursing Homes: Q4 2011 - Q1 2014. (2014). Center for Clinical Standards and Quality/Survey & Certification Group. Interim report on the CMS National Partnership to Improve Dementia Care in Nursing Homes: Q4 2011 – Q1 2014. Retrieved from https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/Downloads/Survey-and-Cert-Letter-14-19.pdf
- Kerns, J. W., Winter, J. D., Winter, K. M., Boyd, T., & Etz, R. S. (2017). primary care physician perspectives about antipsychotics and other medications for symptoms of dementia. Journal of the American Board of Family Medicine. (in press). doi:10.3122/jabfm.2018.01.170230
- Kerns, J. W., Winter, J. D., Winter, K. M., Kerns, C. C., & Etz, R. S. (2017). Caregiver perspectives about using antipsychotics and other medications for symptoms of dementia. Gerontologist. doi:10.1093/geront/gnx042
- Maher, A. R., Maglione, M., Bagley, S., Suttorp, M., Hu, J. H., Ewing, B., … Shekelle, P. G. (2011). Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: A systematic review and meta-analysis. JAMA : the Journal of the American Medical Association, 306(12), 1359–1369. doi:10.1001/jama.2011.1360
- Minimum Data Set 3.0 Public Reports. (2012). CMS.gov. Minimum Data Sets 3.0 Public Reports. Retrieved from https://www.cms.gov/Research-Statistics-Data-and-Systems/Computer-Data-and-Systems/Minimum-Data-Set-3-0-Public-Reports/index.html
- National Institute of Mental Health: Statistics: Prevalence: Schizophrenia. (2016). Retrieved from https://www.nimh.nih.gov/health/statistics/prevalence/schizophrenia.shtml
- Schneider, L. S., Dagerman, K. S., & Insel, P. (2005). Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. JAMA : the Journal of the American Medical Association, 294(15), 1934–1943. doi:10.1001/jama.294.15.1934
- Sink, K. M., Holden, K. F., & Yaffe, K. (2005). Pharmacological treatment of neuropsychiatric symptoms of dementia: A review of the evidence. JAMA : the Journal of the American Medical Association, 293(5), 596–608. doi:10.1001/jama.293.5.596